A Study to Evaluate ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With Unresectable or Metastatic Melanoma
Part of paid clinical trials in Long Beach, California.
- Sponsor
- Amgen
- Study ID
- NCT06054555
- Phase
- PHASE3
- Status
- Active Not Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 99 Years
- Healthy Volunteers
- Not accepted
Interventions
- ABP 206 — DRUGABP 206 will be given intravenously over a period of 30 or 60 minutes, every 4 weeks (Q4W) for a total of 24 months.
- Nivolumab — DRUGNivolumab will be given intravenously over a period of 30 or 60 minutes, Q4W for a total of 24 months.
Study Details
The purpose of this study is to assess the efficacy, safety, and immunogenicity of ABP 206 compared with Nivolumab in Subjects with Treatment-Naïve Unresectable or Metastatic Melanoma.
Key Dates
- Start date
- Nov 2, 2023
- Status verified
- Jan 2026
- Primary completion
- Jan 25, 2028
- Completion
- Jan 25, 2028
Study Design
- Enrollment
- 633 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: ABP 206Subjects will receive Dose A of ABP 206 via intravenous (IV) infusion.
- Active Comparator: NivolumabSubjects will receive Dose A of Nivolumab via IV infusion.
Primary Outcome Measure
Objective response by Week 49 [ Time Frame: Week 49 ]
Locations (5)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Cancer and Blood Specialty clinic | Long Beach | California | 90806 | - |
| Fort Wayne Medical Oncology and Hematology - Office of Clinical Research | Fort Wayne | Indiana | 46825 | - |
| Our Lady of the Lake Physicians Group-Medical Oncology-Woman's Pavilion | Baton Rouge | Louisiana | 70809 | - |
| Oncology Hematology Associates | Springfield | Missouri | 65807-5287 | - |
| Hematology-Oncology Associates of Central New York, P.C. (HOA) - East Syracuse - CCOP | East Syracuse | New York | 13057 | - |
Find similar trials in Long Beach, CA
By condition
By specialty
By research site
Cancer and Blood Specialty clinic· Long Beach, CAFort Wayne Medical Oncology and Hematology - Office of Clinical Research· Fort Wayne, INOur Lady of the Lake Physicians Group-Medical Oncology-Woman's Pavilion· Baton Rouge, LAOncology Hematology Associates· Springfield, MOHematology-Oncology Associates of Central New York, P.C. (HOA) - East Syracuse - CCOP· East Syracuse, NY
Related Studies
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado
- A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)PHASE1/PHASE2 · Recruiting · Merck Sharp & Dohme LLC · Aurora, Colorado
- SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryRecruiting · Massive Bio, Inc. · Birmingham, Alabama
- Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer PatientsPHASE2 · Recruiting · Vyriad, Inc. · Phoenix, Arizona